Assessed likely policy response in major markets to COVID-19

Identified risks to pricing and market access in global markets for related and non-related therapeutic areas

CRA Approach

  • Developed a framework that captures the likely impact of COVID-19 on major markets
  • Examine market’s potential policy response, driven by the economic crisis, the need to invest in health and how these measures might impact medicines
  • Set out an assessment for Client including:
    • The policy changes likely to have the biggest impact
    • Divergence from past approaches that will require a renewed focus for company advocacy and business planning
    • Suggest indicator triggers and/or metrics for prospective monitoring

Client Impact

  • Developed a unique framework to analyse the potential impact of COVID-19 and drivers of policy change in P&R landscape
  • Provided market-based dashboard assessment of scenarios with likelihood and magnitude of impact of COVID-19 on Client portfolio. Identified any potential risks and opportunities to business
  • Moderated discussion to identify implications and mitigation strategies for Client to respond to COVID-19
Related capabilities

Meet our team